New Protein Capital is a venture capital division of VisVires Capital, and is also known as VisVires New Protein (VVNP), that invests in early stage technology companies addressing the growing demand for animal protein in both the food and feed sectors. The venture capital firm was founded by Matthieu Vermersch in 2014, and is headquartered in Singapore. New Protein Capital invests in companies developing innovative solutions to problems faced by the food sector through the development of biotechnology, data science, automation, and supply chain management solutions.
Timeline
Funded Companies
Aleph Farms is an Israeli cellular agriculture start-up founded by Didier Toubia and Shulamit Levenberg in 2017 developing technologies for culturing meat products into 3D structures.
Ynsect is a company that develops ingredients for aquaculture, pet food and fertilizer using insect protein.
mitte is a Germany-based company founded by Karan Sarin, Moritz Waldstein-Wartenberg and Faebian Bastiman.
People
Candice Gomes
Portfolio Management
Caroline Chan
Executive Assistant
Caroline Kouba
Deal-Sourcing Team
Darren Leong
Deal-Sourcing Team
Gerard Chia
Business Development
Kenneth Lee
Senior Partner
Ludovic Plaisant
Deal-Sourcing Team
Marie-Anne Dupin-Vermersch
Research
Matthieu Vermersch
Founder
Thibaut Mercey
Operations
Further reading
SG's VisVires New Protein Capital co-leads $10.6m seed round for smart home water system firm, Mitte
Kristie Neo
Web
SG's VisVires New Protein Capital to launch $100m second fund in 2019, closes $40m first fund
Kristie Neo
Web
Documentaries, videos and podcasts
Matthieu Vermersch, Founder, New Protein Capital from Singapore
April 13, 2017
Companies
MITTE
Nuritas
YNSECT
References
Venture Capital Firm attributes
Categories
Related Topics
Contributors
- 1
Dawson Sewell
Writing about startups. - 2
Tarini Karwal
University of Michigan graduate with a BA in Cognitive Science. Artist and passionate learner. - 3
Melanie Manipula
Helping organize knowledge. - 4
Khadidiatou Amirou
A knowledge enthusiast. - 5
Jude Gomila
Founder and CEO of Golden, Entrepreneur. Investor in 200+ companies. Cantabrigian (Gonville and Caius). Interested in the Universe. - 6
Alex Dean
Healthcare Research Analyst @ Veradigm | Masters in Biostatistics/Epidemiology: UC Berkeley | BA in Biology: Wesleyan University - 7
Amy Tomlinson Gayle
QA Editor based in Austin, TX